S. 1088 - Lower PRICED Drugs Act
- Sponsor:
- Debbie Stabenow
- Summary:
- A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to market exclusivity for certain drugs, and for other purposes. (by CRS)
- Status:
- The bill has been introduced.
Lower PRICED Drugs Act
S. 1088 — 110th Congress (2007–2008)
- Summary
- A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to market exclusivity for certain drugs, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to market exclusivity for certain drugs, and for other purposes.
- Other Titles
- Lower PRICED Drugs Act
- Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act
- Sponsor
- Debbie Stabenow
- Co-Sponsors
- Subjects
- Medicine
- Administrative remedies
- Antibiotics
- Business
- Child health
- Children
- Clinical trials
- Consumer education
- Consumers
- Department of Health and Human Services
- Drug approvals
- Drug industry
- Drug utilization
- Executive departments
- Generic drugs
- Intellectual property
- Labeling
- Law
- Marketing
- Medical care
- Patent infringement
- Patents
- Prescription pricing
- Related Bills
- Major Actions
Introduced 4/11/2007 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 4/11/2007 4/11/2007 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
Contributions data source: OpenSecrets.org